Clinical Trials Directory

Trials / Unknown

UnknownNCT02517827

Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions

Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions A Prospective, Multi-centre, Randomised Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
306 (estimated)
Sponsor
Herz-Zentrums Bad Krozingen · Academic / Other
Sex
All
Age
21 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The endovascular therapy prevailed in nearly all regions of peripheral artery disease over open surgery techniques. However, in treatment of the common femoral artery vascular surgery is still the gold standard of therapy. One-year patency rates are between 90% and 95%. Today, only in selected cases an endovascular procedure for common femoral artery diseases is recommended. The primary objective of this study is to compare the performance of directional atherectomy and drug-coated balloon angioplasty over vascular surgery in common femoral artery lesions in a prospective, multi-center, randomized clinical trial.

Detailed description

Multicenter, prospective, randomized study to be conducted in centers in Europe. A total of 260 subjects will be entered into the study and will be randomized on a 1:1 basis to either directional atherectomy and drug coated balloon angioplasty (optional with stentimplantation), and surgical endarterectomy for treatment in symptomatic (Rutherford-Becker class 2 to 4) common femoral artery disease. All subjects will undergo repeat duplex-ultrasound measurements 6, 12, and 24 months to assess the primary endpoint of Binary Restenosis. Follow-up visits are scheduled 6, 12, and 24 months.

Conditions

Interventions

TypeNameDescription
DEVICEAtherectomy and paclitaxel-coated balloon angioplastyDirectional atherectomy and paclitaxel-coated balloon angioplasty (optional with stentimplantation) of the common femoral artery
PROCEDUREOpen, surgical endarterectomyopen, surgical endarterectomy of the common femoral artery

Timeline

Start date
2017-08-01
Primary completion
2019-12-01
Completion
2021-12-01
First posted
2015-08-07
Last updated
2018-08-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02517827. Inclusion in this directory is not an endorsement.